What is the recommended treatment for cystitis, particularly when caused by bacterial infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Uncomplicated Bacterial Cystitis

For women with uncomplicated bacterial cystitis, prescribe nitrofurantoin 100 mg twice daily for 5 days as first-line therapy, or alternatively trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days if local E. coli resistance is below 20%, or fosfomycin 3 g as a single dose. 1

First-Line Antibiotic Options

The choice among first-line agents depends on local resistance patterns, drug availability, and patient-specific factors:

Nitrofurantoin (Preferred)

  • Dose: 100 mg twice daily for 5 days 1
  • Advantages: Minimal collateral damage to gut flora, low resistance rates, and proven equivalence to trimethoprim-sulfamethoxazole 2
  • Evidence: A randomized trial of 338 women demonstrated 84% clinical cure at 30 days with 5-day nitrofurantoin versus 79% with 3-day trimethoprim-sulfamethoxazole 2

Trimethoprim-Sulfamethoxazole

  • Dose: 160/800 mg (one double-strength tablet) twice daily for 3 days 1
  • Critical caveat: Only use when local E. coli resistance is documented to be <20% 1
  • Resistance concern: Rising resistance rates have demoted this from automatic first-line status, particularly outside the United States 1
  • Clinical failure: In one study, only 41% of women infected with trimethoprim-sulfamethoxazole-resistant organisms achieved clinical cure versus 84% with susceptible isolates 2

Fosfomycin Trometamol

  • Dose: 3 g as a single oral dose 1
  • Advantages: Single-dose convenience, minimal resistance, minimal collateral damage 1
  • Limitation: FDA data suggest inferior efficacy compared to standard short-course regimens 1

Second-Line Options (When First-Line Cannot Be Used)

Fluoroquinolones (Reserve for Resistant Cases)

  • Agents: Ciprofloxacin, levofloxacin, ofloxacin, norfloxacin 1
  • Duration: 3 days 1
  • Strong recommendation: Reserve fluoroquinolones for important uses other than acute cystitis due to high propensity for collateral damage and promotion of resistance 1
  • Only use when: Recommended agents cannot be used due to allergy or documented resistance 1

Beta-Lactam Antibiotics (Use with Caution)

  • Agents: Amoxicillin-clavulanate, cefdinir, cefaclor, cefpodoxime-proxetil 1
  • Duration: 3-7 days 1
  • Cephalexin: 500 mg every 12 hours for 7-14 days for uncomplicated cystitis 3
  • Limitations: Generally inferior efficacy and more adverse effects compared to other UTI antimicrobials 1
  • Use only when: Other recommended agents cannot be used 1

Agents to Avoid

  • Never use amoxicillin or ampicillin empirically due to poor efficacy and very high worldwide resistance rates 1

Special Populations

Men with Uncomplicated Cystitis

  • Same antibiotic choices as women, though true "uncomplicated" cystitis is rare in men 1
  • Consider longer treatment courses given anatomic differences 1

Pregnant Women

  • Avoid nitrofurantoin near term and trimethoprim in first trimester 1
  • Beta-lactams are generally safe options 1

When to Obtain Urine Culture

Do not routinely obtain urine cultures for typical uncomplicated cystitis. 1 Obtain cultures only in these situations:

  • Suspected pyelonephritis 1
  • Symptoms not resolving or recurring within 2-4 weeks after treatment 1
  • Atypical symptoms 1
  • Pregnancy 1

Follow-Up and Treatment Failure

  • No routine post-treatment testing needed for asymptomatic patients 1
  • If symptoms persist or recur within 2 weeks: Obtain urine culture with susceptibility testing and retreat with a different agent for 7 days, assuming resistance to the initial agent 1

Common Pitfalls to Avoid

  • Do not prescribe fluoroquinolones as first-line therapy despite their high efficacy—reserve them for resistant infections to preserve their utility 1
  • Do not assume trimethoprim-sulfamethoxazole will work without knowing local resistance patterns—resistance >20% predicts clinical failure 1, 2
  • Do not extend treatment duration beyond recommended courses without clinical indication—longer courses increase adverse events without improving outcomes 1
  • Do not use beta-lactams as first-line agents unless other options are contraindicated—they have inferior efficacy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.